Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Bullboard Posts
Post by MBAon Dec 19, 2019 10:35pm
218 Views
Post# 30475249

Two Year Trend - Very Positive and Reflective Of Growth

Two Year Trend - Very Positive and Reflective Of GrowthTwo years ago, VMD traded in the $2.40 to $3.20 range. Last year, VMD was trading in the $4.80 - $5.20 area. Now, VMD is trading around $8 which is at the lower end of its last 7 months of trading range. Overall, a solid but volatile trend over the past 2 years. Over this time, VMD has approximately doubled revenue. In the last 6 to 8 months, VMD has also been aggressively continuing its growth and investing in the future as part of preparing for a competitive environment, including investments in technology supporting remote patient monitoring (which should result in a more efficient and lower cost business model). No doubt, these investments have hurt EBITDA margins in the short term. Regardless of what the shorts say, VMD should survive and prosper after the Competitive Bidding process dust settles. I say "should" as there are no guarantees with any company and its future. The objective of CMS isn't to drive companies out of business, the objective is to capture the lowest cost (theoretically) for patient care by leveraging a competitive process. Efficient and effective companies will not only survive, they will continue to earn a fair return on their investment. The competitive bid process is not the same as the prior "30%" cut process. The new prices will be the result of what companies are bidding today to survive and prosper. These bid prices are based on what it costs companies to conduct business and earn a reasonable return on their investment ... the bids are NOT based on some rationale to lose money and to eventually go out of business. Is VMD's business model competitive? If it wasn't, why are they still around and more important, why was Viemed able to grow at 40% + annually for the past x years now? The big question - will the past trend continue into the future? and if so, to what degree? No one knows for sure. Having said that, one thing is fairly certain, there will be companies who will continue serve this untapped market and these companies will continue to capture a higher percentage of the significant UNTAPPED market potential. Welcome 2020, 2021 and beyond. As the years go by, I expect VMD will simple be a much larger company and it has a good chance of being a leader in this industry sector. IMO
Bullboard Posts